ALERT: A Phase II Study of Alternating Eribulin and Hormonal Therapy in Pre-treated ER+ve Breast Cancer.

Condition:   Breast CancerIntervention:   Drug: EribulinSponsor:   Imperial College LondonRecruiting - verified January 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials